ARTICLE | Clinical News
Laszarin trientine regulatory update
May 30, 2005 7:00 AM UTC
FDA granted Fast Track designation to Laszarin to treat heart failure patients with diabetes. Laszarin is an orally-active small molecule that selectively chelates the oxidized form of copper. ...